Free cookie consent management tool by TermsFeed

Our Portfolio

Home > Our Portfolio 

Stimwave Technologies
Seed
Preferred Equity
12/2012

Stimwave Technologies

World’s 1st passive microsize device platform for pain management treatment

      •  No internal batteries or toxic materials
      • Compatible with 3T full body MRI
      • 16-22 Ga needle insertion widens reach targets
      • 1 cm to 6 cm long leads, 0.5 mm to 1.2 mm diameters
      • 2 to 8 electrodes per lead depending on placement Convenient low-cost external ergonomic stimulator wearable unit (SCS shown)
      • 915 MHz ISM band (868 Mhz for EU
      •  Penetration depths to 12 cm (SCS is ~6 cm

Stimwave Technologies  Incorporated and Stimwave LLC (collectively, “Stimwave”) filed a voluntary petition for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code in the District of Delaware on June 15, 2022. Certain Stimwave assets were purchased by Curonix LLC following the bankruptcy sale on October 31, 2022.

Click here for more information about the bankruptcy case.